Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Total investments | ---- | 10.95%2.09B | 10.95%2.09B | 9.09%2B | 5.46%1.94B | -7.98%1.73B | 2.26%1.89B | 2.26%1.89B | 0.31%1.83B | -2.82%1.84B |
-Equity investments | ---- | 1,611.16%941.46M | 1,611.16%941.46M | 1,978.71%1.06B | 778.09%1.14B | -32.44%1.18B | -96.80%55.02M | -96.80%55.02M | -96.98%51.22M | -92.64%129.63M |
-Net loan | ---- | -9.80%40.92M | -9.80%40.92M | -9.78%41.08M | -9.77%41.24M | 9.29%41.38M | 19.71%45.37M | 19.71%45.37M | -2.48%45.53M | -2.53%45.7M |
-Short term investments | ---- | -45.04%926.97M | -45.04%926.97M | -51.89%788.24M | -58.05%658.01M | 147,811.27%406.76M | 613,209.82%1.69B | 613,209.82%1.69B | 595,722.55%1.64B | 570,311.64%1.57B |
-Other invested assets | ---- | 84.65%183.74M | 84.65%183.74M | 8.15%101.48M | 7.36%98.41M | 8.81%99.02M | 15.34%99.51M | 15.34%99.51M | 17.42%93.84M | 12.96%91.66M |
Cash and cash equivalents | -15.66%183.68M | 96.92%200.95M | 96.92%200.95M | 185.42%197.37M | 92.50%153.43M | 309.14%217.79M | 5.58%102.05M | 5.58%102.05M | 30.43%69.15M | -13.30%79.7M |
Receivables | ---- | -1.93%695.81M | -1.93%695.81M | 20.97%875.52M | 20.92%848.11M | 30.30%769.74M | 24.89%709.52M | 24.89%709.52M | 27.00%723.75M | 29.37%701.4M |
-Accounts receivable | ---- | -0.93%681.63M | -0.93%681.63M | 24.98%858.93M | 25.81%828.51M | 35.20%758.22M | 28.21%688.06M | 28.21%688.06M | 29.60%687.28M | 29.50%658.55M |
-Taxes receivable | -31.47%7.9M | -33.93%14.18M | -33.93%14.18M | -54.51%16.59M | -54.26%19.6M | -61.51%11.52M | -31.69%21.46M | -31.69%21.46M | -7.89%36.47M | 27.35%42.85M |
Accrued investment income | -5.42%15.44M | -0.87%15.8M | -0.87%15.8M | -6.95%16.07M | 12.25%16.54M | 6.03%16.33M | 10.04%15.93M | 10.04%15.93M | 13.84%17.27M | 4.68%14.74M |
Prepaid assets | 79.36%44.14M | 62.17%44.89M | 62.17%44.89M | 96.09%42.01M | 153.65%32.9M | 132.83%24.61M | 144.97%27.68M | 144.97%27.68M | 76.45%21.43M | 22.09%12.97M |
Deferred policy acquisition costs | 12.31%151.85M | 16.35%147.22M | 16.35%147.22M | 18.95%149.04M | 17.44%144.04M | 25.79%135.21M | 21.40%126.53M | 21.40%126.53M | 17.78%125.29M | 17.83%122.65M |
Net PPE | 1.41%136.25M | 1.32%136.02M | 1.32%136.02M | 1.12%135.38M | 0.50%134.62M | 0.82%134.35M | 0.85%134.25M | 0.85%134.25M | 0.62%133.89M | -0.69%133.95M |
Goodwill and other intangible assets | -15.98%3.73M | -15.36%3.91M | -15.36%3.91M | -14.79%4.08M | -14.27%4.26M | -13.78%4.44M | -13.32%4.62M | -13.32%4.62M | -12.89%4.79M | -12.48%4.97M |
-Other intangible assets | ---- | -15.36%3.91M | -15.36%3.91M | ---- | ---- | ---- | -13.32%4.62M | -13.32%4.62M | ---- | ---- |
Other assets | 1,475.67%2.99B | 3.45%127.76M | 3.45%127.76M | 29.03%116.81M | 25.65%112.33M | 113.41%189.69M | 39.27%123.5M | 39.27%123.5M | 21.83%90.53M | 7.05%89.39M |
Total assets | 8.74%3.53B | 10.95%3.49B | 10.95%3.49B | 16.20%3.55B | 12.95%3.41B | 11.95%3.24B | 9.09%3.14B | 9.09%3.14B | 8.26%3.05B | 4.60%3.02B |
Liabilities | ||||||||||
Policy holders liabilities reserve | 8.04%2.46B | 10.52%2.42B | 10.52%2.42B | 11.26%2.44B | 11.01%2.39B | 14.44%2.28B | 10.98%2.19B | 10.98%2.19B | 12.53%2.2B | 11.10%2.15B |
Long term debt and capital lease obligation | ---- | 134.12%117.06M | 134.12%117.06M | 134.02%117.01M | 133.93%116.97M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M |
-Long term debt | ---- | 134.12%117.06M | 134.12%117.06M | 134.02%117.01M | 133.93%116.97M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M |
Other liabilities | 38.65%249.91M | -0.38%171.65M | -0.38%171.65M | 24.52%198.32M | 26.40%175.75M | 69.37%180.24M | 42.98%172.31M | 42.98%172.31M | 38.12%159.26M | 18.99%139.04M |
Total liabilities | 8.08%2.71B | 12.30%2.71B | 12.30%2.71B | 14.69%2.76B | 14.55%2.68B | 16.83%2.51B | 12.52%2.41B | 12.52%2.41B | 13.63%2.41B | 11.27%2.34B |
Shareholders'equity | ||||||||||
Share capital | ---- | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K |
-common stock | ---- | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K |
Paid-in capital | 2.84%216.88M | 2.79%215.85M | 2.79%215.85M | 1.64%213.37M | 1.60%212.33M | 1.38%210.89M | 1.43%209.99M | 1.43%209.99M | 1.51%209.93M | 1.37%208.99M |
Retained earnings | 8.53%634M | 7.96%620.44M | 7.96%620.44M | 6.07%593.05M | 3.69%577.36M | -5.36%584.15M | -7.39%574.69M | -7.39%574.69M | -7.50%559.13M | -11.83%556.79M |
Gains losses not affecting retained earnings | ---- | -7.50%-54.78M | -7.50%-54.78M | 83.38%-20.63M | 29.43%-63.12M | 20.64%-58.29M | 41.76%-50.96M | 41.76%-50.96M | -12.34%-124.15M | -57.54%-89.44M |
Total stockholders'equity | 15.49%850.88M | 6.51%781.53M | 6.51%781.53M | 21.84%785.82M | 7.43%726.6M | -2.00%736.77M | -0.86%733.75M | -0.86%733.75M | -7.97%644.94M | -13.39%676.37M |
Total equity | 10.98%817.66M | 6.51%781.53M | 6.51%781.53M | 21.84%785.82M | 7.43%726.6M | -2.00%736.77M | -0.86%733.75M | -0.86%733.75M | -7.97%644.94M | -13.39%676.37M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |